XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
This intro covers scenarios where a price-weighted index may be appropriate and how it contrasts with alternative indexing methods.
22,669 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Oil prices jump and stock futures wobble as Middle East tensions escalate. Traders weigh what 'iran’s supreme leader ...
Vanguard’s FTSE Emerging Markets ETF (VWO) omits South Korea due to a 2009 reclassification, leaving investors expose...
The commercial space backlog has eclipsed $500 billion as SpaceX files an S-1 and Rocket Lab targets a 2026 launch, b...
SOXQ has surged 181.74% in the past year as AI chip demand powers gains across NVIDIA, Broadcom, and AMD, while the E...
Friday's 14% plunge in ProShares UltraPro QQQ wiped out most of the gains from a high-octane tech rally, illustrating...
National Case-Shiller data shows real price gains disappeared in 2025 as inflation ran hotter than housing, with the ...
Warren Buffett’s blunt warning that today’s market mood resembles gambling hits a nerve with everyday investors. This...
Warren Buffett's decades-long investing journey shows that patience and a focus on quality beat flashier moves. This ...
A memory themed ETF is drawing intense inflows, triggering questions about momentum versus risk. This guide breaks do...
Two concrete signals could shape the S&P 500 this week in the wake of Signet Jewelers' earnings. This guide explains ...
When markets surge, two traps catch many investors off guard. This practical guide reveals the incredibly costly mist...